The state has received 3,000 doses of Bamlanivimab, a monoclonal antibody therapy. The process can be complicated but the hope is it cuts down on hospitalizations.
KUSA would like to send you push notifications about the latest news and weather.
Notifications can be turned off anytime in the browser settings.
